-
1 Comment
Australian Primary Hemp Limited is currently in a long term uptrend where the price is trading 6.5% above its 200 day moving average.
From a valuation standpoint, the stock is 91.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.9.
Australian Primary Hemp Limited's total revenue rose by 51.8% to $742K since the same quarter in the previous year.
Its net income has increased by 78.3% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 49.7% to $-607K since the same quarter in the previous year.
Based on the above factors, Australian Primary Hemp Limited gets an overall score of 5/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU0000182867 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Beta | 4.55 |
---|---|
Target Price | 4.45 |
Market Cap | 28M |
PE Ratio | None |
Dividend Yield | None |
Australian Primary Hemp Limited produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. Australian Primary Hemp Limited was incorporated in 1995 and is based in Newtown, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for APH.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025